. Indicators of rapid cognitive decline in amnestic mild cognitive impairment: The role of plasma biomarkers using magnetically labeled immunoassays. J Psychiatr Res. 2020 Oct;129:66-72. Epub 2020 Jun 9 PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ40
(Plasma)
AD
(19)
52.7 ± 3.2
pg/mL
Immunomagnetic Reduction;
MF-AB0-0060;
MagQu Co. Ltd.
McKhann et al., 2011
Aβ40
(Plasma)
CTRL-
CNC
(10)
53 ± 4.8
pg/mL
Immunomagnetic Reduction;
MF-AB0-0060;
MagQu Co. Ltd.
Aβ42
(Plasma)
AD
(19)
17.4 ± 0.9
pg/mL
Immunomagnetic Reduction;
MF-AB2-0060;
MagQu Co. Ltd.
McKhann et al., 2011
Aβ42
(Plasma)
CTRL-
CNC
(10)
16.6 ± 0.7
pg/mL
Immunomagnetic Reduction;
MF-AB2-0060;
MagQu Co. Ltd.
tau-p181
(Plasma)
AD
(19)
3.8 ± 0.7
pg/mL
Immunomagnetic Reduction;
MF-PT1-0060;
MagQu
McKhann et al., 2011
tau-p181
(Plasma)
CTRL-
CNC
(10)
3.4 ± 0.6
pg/mL
Immunomagnetic Reduction;
MF-PT1-0060;
MagQu
tau-total
(Plasma)
AD
(19)
26.4 ± 4.2
pg/mL
Immunomagnetic Reduction;
MF-TAU-0060;
MagQu
McKhann et al., 2011
tau-total
(Plasma)
CTRL-
CNC
(10)
23 ± 3.5
pg/mL
Immunomagnetic Reduction;
MF-TAU-0060;
MagQu
α-synuclein
(Plasma)
AD
(19)
145.1 ± 78
fg/mL
Immunomagnetic Reduction;
MF-ASC-0060;
MagQu Co. Ltd.
McKhann et al., 2011
α-synuclein
(Plasma)
CTRL-
CNC
(10)
115.8 ± 83.9
fg/mL
Immunomagnetic Reduction;
MF-ASC-0060;
MagQu Co. Ltd.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.